Evidence Requirements for Future-Treatment Evidence in Vascular Emergency Claims

Clinical Foundations in Vascular Emergency Litigation

In clinical negligence litigation involving acute cardiovascular events, the determination of future treatment requirements often hinges on the distinction between the natural history of a condition and the incremental impact of an alleged breach of duty. For solicitors, establishing a robust evidential foundation for future care and intervention is essential to meeting the claimant’s burden of proof regarding quantum.

Medico-legal assessment of future treatment needs requires an expert to evaluate the initial presentation against the Civil Procedure Rules (CPR) Part 35 duty to provide an independent, unbiased opinion. The cardiologist must first establish the physiological baseline, distinguishing between the patient’s pre-existing cardiovascular risk profile and any exacerbation resulting from the alleged index events. This assessment frequently incorporates established clinical frameworks, such as risk stratification scores, to contextualise whether the patient’s subsequent management, including ongoing surveillance or secondary preventative therapy, was a direct consequence of the clinical outcome or a foreseeable necessity of the underlying pathology.

Assessment of Future Treatment Needs

Calculating the trajectory of future care involves a synthesis of clinical prognosis and the long-term impact of the index event. When assessing the projected requirements for clinical management, experts must consider whether recommended interventions, such as serial imaging or long-term pharmacotherapy, are necessitated by the initial cardiac injury or whether they would have been required in any event due to the patient’s underlying condition. Under the Bolitho v City and Hackney HA [1998] framework, the expert’s opinion must be capable of withstanding logical analysis; therefore, a speculative future treatment schedule is rarely sufficient to justify a claim for future losses. Solicitors should ensure that medical records clearly delineate surveillance intervals, pharmacy logs, and specialist follow-up notes to provide the evidentiary weight required to satisfy the court.

Procedural Framework and Expert Collaboration

Proportionality remains a core pillar of civil litigation. Under CPR 35.7, the court may direct the appointment of a single joint expert (SJE) to provide a report on specific issues, such as the necessity of long-term surveillance, to avoid unnecessary costs and duplication. Where an SJE is appointed, they are instructed under CPR 35.8. This process differs fundamentally from the procedures under CPR 35.12, where separately instructed experts are directed by the court or choose to discuss and prepare a joint statement. A joint statement allows experts to narrow the issues and identify areas of consensus while clarifying points of divergence. Instructing solicitors must ensure that the expert is provided with a comprehensive and chronological set of medical records to support their analysis of causation and the resultant future treatment liability.

Common Pitfalls in Future-Loss Substantiation

One of the primary challenges in vascular claims is the risk of overstating the causal link between the breach and the future need. If the patient has an inherited cardiac condition or pre-existing hypertension, the expert must distinguish the requirement for ongoing treatment caused by the natural evolution of these diseases versus those specifically necessitated by the sequelae of the alleged clinical failure. Reliance on vague prognostications or generic treatment pathways can undermine the reliability of the evidence. Instead, the expert’s report should be tethered to identifiable clinical benchmarks, ensuring that the assessment of future loss aligns with the medical reality of the patient’s cardiac function, ejection fraction, and long-term symptom burden.

• Ensure the expert distinguishes between pre-existing pathology and index-event consequences.
• Avoid reliance on speculative future treatment schedules without clinical documentation.
• Ensure the report addresses whether long-term interventions follow the ‘but-for’ causation test.
• Verify that expert discussions under CPR 35.12, where appropriate, are focused on narrowing specific points of technical disagreement.